By Dean Seal
The chief executive of Assertio Holdings is stepping down and will be succeeded for the time being by an independent director.
The specialty pharmaceutical company said Wednesday that Dan Peisert is departing but didn’t provide a reason. Chairman Peter Staple thanked Peisert for his contributions to Assertio as its chief executive and chief financial officer before that.
The board has tapped Heather Mason, an independent director and chair of its nominating and corporate governance committee, to serve as interim chief executive while the company searches for a permanent successor.
Mason has been on the board since 2019 and previously held leadership roles at Abbott Laboratories.
Write to Dean Seal at dean.seal@wsj.com
Read the full article here
